Progestogens exhibit progestogen-, promoter-and isoform-specific effects via the progesterone receptor

K Enfield, C Avenant, JP Hapgood - Steroids, 2022 - Elsevier
Hormonal contraceptives (HCs) and hormone replacement therapy (HRT) are therapies
designed to target the progesterone receptor (PR) to prevent unwanted pregnancy and to …
被引用次数：3 相关文章

Progestogens Exhibit Progestogen-, Promoter-and Isoform-Specific Effects Via the Progesterone Receptor

K Enfield, C Avenant, JP Hapgood - … -and Isoform-Specific Effects Via the … - papers.ssrn.com
Hormonal contraceptives (HCs) and hormone replacement therapy (HRT) are therapies
designed to target the progesterone receptor (PR) to prevent unwanted pregnancy and to …

Progestogens exhibit progestogen-, promoter-and isoform-specific effects via the progesterone receptor.

K Enfield, C Avenant, JP Hapgood - Steroids, 2022 - europepmc.org
Hormonal contraceptives (HCs) and hormone replacement therapy (HRT) are therapies
designed to target the progesterone receptor (PR) to prevent unwanted pregnancy and to …
[HTML] nih.gov

[HTML][HTML] Progestogens exhibit progestogen-, promoter-and isoform-specific effects via the progesterone receptor

K Enfield, C Avenant, JP Hapgood - Steroids, 2022 - ncbi.nlm.nih.gov
Hormonal contraceptives (HCs) and hormone replacement therapy (HRT) are therapies
designed to target the progesterone receptor (PR) to prevent unwanted pregnancy and to …

Progestogens exhibit progestogen-, promoter-and isoform-specific effects via the progesterone receptor

K Enfield, C Avenant, JP Hapgood - Steroids, 2022 - pubmed.ncbi.nlm.nih.gov
Hormonal contraceptives (HCs) and hormone replacement therapy (HRT) are therapies
designed to target the progesterone receptor (PR) to prevent unwanted pregnancy and to …